[optimal] Re: [External] Re: ICOP Scientific Abstract Submission Deadline January 15th

  • From: "Bennett, Timothy" <tbennett1@xxxxxxxxxxxxxxxxxxxxxxx>
  • To: "Miller, CRA, OCT-C, Gary" <gmiller@xxxxxxxxxxxxx>, "optimal@xxxxxxxxxxxxx" <optimal@xxxxxxxxxxxxx>
  • Date: Thu, 9 Jan 2020 18:34:32 +0000

My guess is that the ICOP program committee would group together talks with 
similar or complementary topics, so it would kind of work the same way we've 
organized PTT. That's what's so cool about the short paper format.

Sounds like you plan to go to Rotterdam. I think most of the ICOP "usual 
suspects" will also be going. Anybody else out there in Optimal land planning 
on it?

tim


From: Miller, CRA, OCT-C, Gary [mailto:gmiller@xxxxxxxxxxxxx]
Sent: Thursday, January 09, 2020 9:43 AM
To: Bennett, Timothy <tbennett1@xxxxxxxxxxxxxxxxxxxxxxx>; optimal@xxxxxxxxxxxxx
Subject: Re: [External] [optimal] Re: ICOP Scientific Abstract Submission 
Deadline January 15th


Ohhhh, that's a BINGO, Tim!

I was thinking a Pearls Tips and Tactics presentation. I think we could get 30  
minutes, 3 or 4 SHORT talks (5-7 minutes) or do back to back like you 
mentioned. The PTT always went over well in Hershey, New Orleans and Chicago... 
to name a few..... and I thought Paula Morris'  Mission Impossible in SF was 
well received too! That was a very similar format to your PTT talks.....

I'm betting you can get one or three folks to join you! ; )

Gotta love McGyver!! (sp?)

Gary

________________________________
From: optimal-bounce@xxxxxxxxxxxxx<mailto:optimal-bounce@xxxxxxxxxxxxx
<optimal-bounce@xxxxxxxxxxxxx<mailto:optimal-bounce@xxxxxxxxxxxxx>> on behalf 
of Bennett, Timothy 
<tbennett1@xxxxxxxxxxxxxxxxxxxxxxx<mailto:tbennett1@xxxxxxxxxxxxxxxxxxxxxxx>>
Sent: Thursday, January 9, 2020 8:53 AM
To: optimal@xxxxxxxxxxxxx<mailto:optimal@xxxxxxxxxxxxx
<optimal@xxxxxxxxxxxxx<mailto:optimal@xxxxxxxxxxxxx>>
Subject: [External] [optimal] Re: ICOP Scientific Abstract Submission Deadline 
January 15th


There's a couple ways it could be done. Two different perspectives on the same 
topic is the most obvious. So for example you have done a lot of work in ultra 
wide imaging with the Optos. Maybe collaborating with someone that uses a 
different widefield device or both people show different cases with the same 
device or technique.



I'm assuming the talks are 15 minutes? If you had a topic that might go longer 
than that, you could attempt to split it into two presentations by two 
different presenters to make sure it all gets covered. That would assume that 
both talks get selected by the committee, but maybe somehow they could be 
flagged as a pair when submitting.



Gary Miller and I have collaborated on related short topics in the past.  One 
of our favorites is "The Top 10 Uses of a 2x4 in Ophthalmology". I've also done 
the tag-team approach with several MDs (I do the technical part and they show 
how they use images clinically). It's definitely a fun way to present and I 
just suggest it as an idea to get people thinking about topics to present. 
Sometimes having a collaborator can take the stress out of preparing a talk and 
abstract.



tim



From: optimal-bounce@xxxxxxxxxxxxx<mailto:optimal-bounce@xxxxxxxxxxxxx
[mailto:optimal-bounce@xxxxxxxxxxxxx] On Behalf Of Olivia Rainey
Sent: Wednesday, January 08, 2020 5:00 PM
To: optimal@xxxxxxxxxxxxx<mailto:optimal@xxxxxxxxxxxxx>
Subject: [optimal] Re: ICOP Scientific Abstract Submission Deadline January 15th





Thanks Tim!



I have been thinking about submitting since I found out I am able to submit, 
even with being the chair.

I would be interested in a tag-team presentation too.



Let me know how that would work!



--

Olivia Rainey, OCT-C, COA

Board of Education

Ophthalmic Photographer's 
Society<https://urldefense.com/v3/__https:/nam05.safelinks.protection.outlook.com/?url=https*3A*2F*2Furldefense.com*2Fv3*2F__https*3A*2Fwww.opsweb.org*2F__*3B!!Ls64Rlj6!ifKt3bQX6injL9qrBnbV_vDr8CDzTevQUsvEQrCBqAfkCpHktwlPx9en8rSX1_w86r6ORHdtTg*24&data=02*7C01*7Cgmiller*40geisinger.edu*7Cc2942ca355d94542af5408d7950b5ab0*7C37d46c567c664402a16055c2313b910d*7C0*7C0*7C637141748316384894&sdata=vBpCSHR2l*2BS6EPm8ExQuE4Wx95w*2FcETDy0qG7wU3wew*3D&reserved=0__;JSUlJSUlJSUlJSUlJSUlJSUlJSUl!!Ls64Rlj6!m3sY1eqrtr6dvdivGiXJGXAvtSRxo9K3wlPvA5WTYnncuvVp-zf6cYAb6DgNaXPfynvtiVCFBg$>

Retina Specialists of 
Michigan<https://urldefense.com/v3/__https:/nam05.safelinks.protection.outlook.com/?url=https*3A*2F*2Furldefense.com*2Fv3*2F__http*3A*2Fwww.retinaspecialistsofmichigan.com__*3B!!Ls64Rlj6!ifKt3bQX6injL9qrBnbV_vDr8CDzTevQUsvEQrCBqAfkCpHktwlPx9en8rSX1_w86r4Xcmui3Q*24&data=02*7C01*7Cgmiller*40geisinger.edu*7Cc2942ca355d94542af5408d7950b5ab0*7C37d46c567c664402a16055c2313b910d*7C0*7C0*7C637141748316394889&sdata=MbF4uX0aaRve37IDEA2cLEiJ*2BQhYuM9QyFaaQ40ebUs*3D&reserved=0__;JSUlJSUlJSUlJSUlJSUlJSUlJQ!!Ls64Rlj6!m3sY1eqrtr6dvdivGiXJGXAvtSRxo9K3wlPvA5WTYnncuvVp-zf6cYAb6DgNaXPfyntoqMVOhQ$>

P: 616-214-9520

W: 616-954-2020





On Wed, Jan 8, 2020 at 12:21 PM Bennett, Timothy 
<tbennett1@xxxxxxxxxxxxxxxxxxxxxxx<mailto:tbennett1@xxxxxxxxxxxxxxxxxxxxxxx>> 
wrote:

Thanks Olivia. If anyone wants to collaborate on an abstract/presentation, let 
me know. I already submitted a solo idea, but sometimes it's more fun to 
"tag-team" a topic.



Looking forward to Rotterdam!



tim



From: optimal-bounce@xxxxxxxxxxxxx<mailto:optimal-bounce@xxxxxxxxxxxxx
[mailto:optimal-bounce@xxxxxxxxxxxxx<mailto:optimal-bounce@xxxxxxxxxxxxx>] On 
Behalf Of Olivia Rainey
Sent: Tuesday, January 07, 2020 9:03 PM
To: optimal@xxxxxxxxxxxxx<mailto:optimal@xxxxxxxxxxxxx>
Subject: [optimal] ICOP Scientific Abstract Submission Deadline January 15th





Just a reminder that the deadline for ICOP submissions in Rotterdam, 
Netherlands is only one week away on January 15th, 2020!



LINK: 
https://www.opsweb.org/page/ICOPAbstracts2020<https://urldefense.com/v3/__https:/nam05.safelinks.protection.outlook.com/?url=https*3A*2F*2Furldefense.com*2Fv3*2F__https*3A*2Fwww.opsweb.org*2Fpage*2FICOPAbstracts2020__*3B!!Ls64Rlj6!iQCyt1JV3hvNILQ1YjqChkvyVR46Mii7pp9mVoCmQ76kvJPryi2An0FJoWPBvDRwig7pTUCUbQ*24&data=02*7C01*7Cgmiller*40geisinger.edu*7Cc2942ca355d94542af5408d7950b5ab0*7C37d46c567c664402a16055c2313b910d*7C0*7C0*7C637141748316394889&sdata=FmXZI0l6OYSnguPBX4Nn7zIpcI7MxTu*2Fy3ICKipfems*3D&reserved=0__;JSUlJSUlJSUlJSUlJSUlJSUlJSUl!!Ls64Rlj6!m3sY1eqrtr6dvdivGiXJGXAvtSRxo9K3wlPvA5WTYnncuvVp-zf6cYAb6DgNaXPfynvkVawWmg$>



These presentations are an excellent way to share your knowledge, your 
experiences, and give other attendees a chance to learn how ophthalmic imaging 
is practiced around the world. It only takes that first small step to start the 
rewarding process of developing a valuable and respected sharing of ideas!



Kind regards,

Olivia



--

Olivia Rainey, OCT-C, COA

Board of Education

Ophthalmic Photographer's 
Society<https://urldefense.com/v3/__https:/nam05.safelinks.protection.outlook.com/?url=https*3A*2F*2Furldefense.com*2Fv3*2F__https*3A*2Fwww.opsweb.org*2F__*3B!!Ls64Rlj6!iQCyt1JV3hvNILQ1YjqChkvyVR46Mii7pp9mVoCmQ76kvJPryi2An0FJoWPBvDRwig7djZWpKg*24&data=02*7C01*7Cgmiller*40geisinger.edu*7Cc2942ca355d94542af5408d7950b5ab0*7C37d46c567c664402a16055c2313b910d*7C0*7C0*7C637141748316404886&sdata=knQJvGqADSymjuWw0mSTroMfD6BT0qJA7DnkDkgIVQc*3D&reserved=0__;JSUlJSUlJSUlJSUlJSUlJSUlJQ!!Ls64Rlj6!m3sY1eqrtr6dvdivGiXJGXAvtSRxo9K3wlPvA5WTYnncuvVp-zf6cYAb6DgNaXPfynt-E6x5Iw$>

Retina Specialists of 
Michigan<https://urldefense.com/v3/__https:/nam05.safelinks.protection.outlook.com/?url=https*3A*2F*2Furldefense.com*2Fv3*2F__http*3A*2Fwww.retinaspecialistsofmichigan.com__*3B!!Ls64Rlj6!iQCyt1JV3hvNILQ1YjqChkvyVR46Mii7pp9mVoCmQ76kvJPryi2An0FJoWPBvDRwig6FO7H5FA*24&data=02*7C01*7Cgmiller*40geisinger.edu*7Cc2942ca355d94542af5408d7950b5ab0*7C37d46c567c664402a16055c2313b910d*7C0*7C0*7C637141748316414879&sdata=WlyY0sXJFu93n7E3sYzop64*2F8voBe5NqFti9oDxYojI*3D&reserved=0__;JSUlJSUlJSUlJSUlJSUlJSUlJQ!!Ls64Rlj6!m3sY1eqrtr6dvdivGiXJGXAvtSRxo9K3wlPvA5WTYnncuvVp-zf6cYAb6DgNaXPfyntxaXPfPQ$>

P: 616-214-9520

W: 616-954-2020

________________________________

IMPORTANT WARNING: The information in this message (and the documents attached 
to it, if any) is confidential and may be legally privileged. It is intended 
solely for the addressee. Access to this message by anyone else is 
unauthorized. If you are not the intended recipient, any disclosure, copying, 
distribution or any action taken, or omitted to be taken, in reliance on it is 
prohibited and may be unlawful. If you have received this message in error, 
please delete all electronic copies of this message (and the documents attached 
to it, if any), destroy any hard copies you may have created and notify me 
immediately by replying to this email. Thank you. Geisinger Health System 
utilizes an encryption process to safeguard Protected Health Information and 
other confidential data contained in external e-mail messages. If email is 
encrypted, the recipient will receive an e-mail instructing them to sign on to 
the Geisinger Health System Secure E-mail Message Center to retrieve the 
encrypted e-mail.

Other related posts: